Influenza virus vaccine intranasal - Mymetics

Drug Profile

Influenza virus vaccine intranasal - Mymetics

Latest Information Update: 21 Nov 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mymetics Corporation
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Influenza virus infections

Most Recent Events

  • 21 Nov 2016 Development for Influenza virus infections is ongoing (Mymetics pipeline, November 2016)
  • 21 Nov 2016 Influenza virus vaccine intranasal - Mymetics is available for licensing as of 21 Nov 2011. http://
  • 05 Oct 2011 Influenza virus vaccine intranasal - Mymetics is available for licensing as of 04 Oct 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top